1st July 2024 by Dr Louise Hudman
This is a new guideline from Nice advising that empagliflozin can now be used in the treatment of CKD. It was published in December 2023.
Dapagliflozin was recommended by Nice for the treatment of CKD back in 2022. It has slightly tighter prescribing recommendations.
You can also read more on CKD in my previous blog.
Vibegron in overactive bladder syndrome (Nice, 2024)
Like Mirabegron, Vibegron is also a beta-3 adrenergic receptor agonist.
Last chance to sign up for free GP physical activity webinar
GP speaker Dr Varun Anand will present ‘Physical activity for long-term conditions’ for NASGP’s last webinar of 2024.
Genetic testing for clopidogrel response (Nice 2024)
It advises that CYP2C19 genotype testing can be carried out on certain people to see if they will respond to clopidogrel.
"I have found membership very helpful during my time as a GP locum and would like to thank you very much."
Dr Louise Napier-Hemy, GP